Skip to content

Comparison of different dosage of oxytocin for initiating uterine contraction during cesarean delivery: A randomized, double-blind, controlled, non-inferiority trial

Comparison of different dosage of oxytocin for initiating uterine contraction during cesarean delivery: A randomized, double-blind, controlled, non-inferiority trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190415001
Enrollment
Unknown
Registered
2019-04-15
Start date
2018-11-11
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adequate uterine contraction at 3 minutes Uterine contraction (verbal numerical scale 0 &#45

Interventions

administration oxytocin 5 IU (drug was diluted with NSS upto 10 ml) at delivery time more than 15 seconds,administration oxytocin 10 IU (drug was diluted with NSS upto 10 ml) at delivery time slowly m
Experimental Drug,Active Comparator Drug
oxytocin 5 IU,oxytocin 10 IU

Sponsors

Khon Kaen University
Lead Sponsor
Khon Kaen University
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASA physical status class II singleton pregnancy gestational age 37-42 weeks patients were planned for cesarean delivery patients were planned for spinal anesthesia

Exclusion criteria

Exclusion criteria: failed or inadequate spinal anesthesia high risk of uterine atony (macrosomia, twins, chorioamnionitis, polyhydramnios, myoma uteri) previous uterus surgery (except cesarean section) high risk of postpartum hemorrhage (placenta previa, history of previous postpatum hemorrhage, coagulopathy, thrombocytopenia, PIH) contraindication of spinal anesthesia allergy to oxytocin refuse to be volunteer

Design outcomes

Primary

MeasureTime frame
adequate uterine contraction at 3 minutes after oxytocin administration evaluated by surgeon

Secondary

MeasureTime frame
effectiveness administration time - 15 minutes after administration additional doses of uterotonic drugs, additional obstetrics procedures, uterine contraction (verbal ,adverse effects administration time - 15 minutes after administration told by subjects, evaluated by outcome assessor

Countries

Thailand

Contacts

Public ContactMonsicha Somjit

Khon Kaen University

monsicha@kku.ac.th+66-955655500

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026